Comparing Lorcaserin Versus Duloxetine for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Status:
Unknown status
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
A Randomized Phase II study Comparing Lorcaserin versus Duloxetine for the Treatment of
Chemotherapy-Induced Peripheral Neuropathy Produced by Oxaliplatin